KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Jul 12, 2023 $20.22 $20.96 $19.80 $20.26 757 486
Jul 11, 2023 $20.00 $20.32 $19.69 $19.89 559 638
Jul 10, 2023 $18.81 $19.88 $18.52 $19.87 707 006
Jul 07, 2023 $18.82 $19.38 $18.61 $18.68 431 987
Jul 06, 2023 $18.66 $18.78 $18.12 $18.58 526 927
Jul 05, 2023 $19.30 $19.55 $18.80 $19.02 411 216
Jul 03, 2023 $18.88 $19.48 $18.70 $19.36 263 828
Jun 30, 2023 $19.15 $19.39 $18.58 $18.75 535 881
Jun 29, 2023 $19.48 $19.63 $18.58 $18.77 647 189
Jun 28, 2023 $18.92 $19.53 $18.66 $19.40 527 331
Jun 27, 2023 $18.18 $18.91 $17.90 $18.79 464 737
Jun 26, 2023 $18.50 $18.64 $17.62 $18.10 806 833
Jun 23, 2023 $18.46 $18.76 $18.18 $18.55 839 607
Jun 22, 2023 $18.90 $19.01 $18.56 $18.64 428 130
Jun 21, 2023 $19.42 $19.42 $18.42 $18.99 603 409
Jun 20, 2023 $19.70 $20.20 $18.88 $19.69 980 297
Jun 16, 2023 $20.97 $21.42 $19.30 $19.90 1 802 492
Jun 15, 2023 $17.51 $19.97 $16.96 $19.84 1 953 678
Jun 14, 2023 $18.05 $18.38 $17.01 $17.10 517 294
Jun 13, 2023 $17.41 $18.77 $17.39 $18.12 606 922
Jun 12, 2023 $17.29 $18.38 $17.26 $17.45 601 053
Jun 09, 2023 $17.79 $17.83 $17.15 $17.19 366 437
Jun 08, 2023 $17.54 $18.10 $17.13 $17.59 356 125
Jun 07, 2023 $18.10 $18.26 $17.54 $17.66 516 605
Jun 06, 2023 $16.82 $18.18 $16.74 $17.95 618 619
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT